Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 20, 2023 07:30 ET | Source: OpGen, Inc.

OpGen Presents Unyvero Urinary Tract Infection Panel Trial Results at ASM Microbe 2023 Conference

‘Multi-Center Clinical Trial Using a Novel Semi-Quantitative Multiplex-PCR Based Diagnostic Panel for Urinary Tract Specimens’ presented on June 17th, 2023Presentation focused on primary study...
September 05, 2019 07:00 ET | Source: Summit Therapeutics plc

Summit Presented In Vivo Proof of Concept Data for Targeted Enterobacteriaceae Antibiotics at ASM/ESCMID Conference

Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Presents In Vivo Proof of Concept Data for Targeted Enterobacteriaceae Antibiotic at ASM/ESCMID Conference New Mechanism Antibiotic...
June 20, 2019 07:00 ET | Source: Summit Therapeutics plc

Summit to Present on Pipeline and Strategy for its New Classes of Antibiotics at ASM Microbe 2019

Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit to Present on Pipeline and Strategy for its New Classes of Antibiotics at ASM Microbe 2019 Oxford, UK, and Cambridge, MA, US,...
May 30, 2018 09:00 ET | Source: GeoVax, Inc.

GeoVax to Present at the 2018 ASM Microbe Conference

ATLANTA, GA. , May 30, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), winner of the 2018 “Best Biotech” Vaccine Industry Excellence Award at the World Vaccine Congress, announced today...
June 21, 2016 16:01 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces New Data at ASM Microbe 2016 Demonstrating Benefits of Adopting T2Candida® Panel for Diagnosing Sepsis in Clinical Settings

LEXINGTON, Mass., June 21, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced the T2Candida®...
June 21, 2016 07:00 ET | Source: ContraFect Corporation

ContraFect Presents New CF-301 Data at ASM Microbe 2016

YONKERS, NY--(Marketwired - June 21, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
June 20, 2016 12:30 ET | Source: Summit Therapeutics PLC

Summit’s Ridinilazole Preserves Microbiome During Treatment of C. Difficile Infection

Microbiome-Sparing Action of Ridinilazole associated with Superiority over Vancomycin in Sustained Clinical Response Rate OXFORD, United Kingdom, June 20, 2016 (GLOBE NEWSWIRE) -- Summit...
June 08, 2016 06:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Presentations at ASM Microbe 2016

LEXINGTON, Mass., June 08, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced the T2Candida®...